J. Dewar

Evaluation of a Remote Symptom Assessment and Management (SAM) System for People Receiving Adjuvant Chemotherapy for Breast or Colorectal Cancer: Mixed Methods Study (Preprint)

L. Whitehead, L. Emery, Deborah Kirk, 2020 .

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study.

J. Albanell, M. Campone, P. Fumoleau, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Long‐term follow‐up of elderly patients with locoregional breast cancer treated with tamoxifen only

A. Cuschieri, J. Dewar, J. Dewar, 1991, The British journal of surgery.

Rational use of trastuzumab in metastatic and locally advanced breast cancer: implications of recent research.

S. Goel, P. Francis, L. Mileshkin, 2011, Breast.

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.

D. Goldstein, M. Tattersall, S. Ackland, 1997, Seminars in Oncology.

Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand.

D. Goldstein, M. Tattersall, S. Ackland, 1997, Oncology.

Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.

J. Forbes, V. Gebski, R. Simes, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

M. Tattersall, D. Goldstein, M. Tattersall, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial P aclitaxel I mproves O utcome C ompared W ith C MFP Combination C hemotherapy a s F ront-Line T herapy in U ntreated M etastatic B reast C ancer

D. Goldstein, S. Ackland, J. Dewar, 1999 .

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

R. Gelber, W. McCaskill-Stevens, P. Francis, 2009, Breast Cancer Research and Treatment.

The Use of Bone Markers in a 6-Week Study to Assess the Efficacy of Oral Clodronate in Patients with Metastatic Bone Disease

E. McCloskey, D. Cameron, M. Ruutu, 2007, Calcified Tissue International.